University of Pittsburgh Medical Center, Pittsburgh, PA.
J Cardiothorac Vasc Anesth. 2022 Jun;36(6):1552-1564. doi: 10.1053/j.jvca.2021.06.036. Epub 2021 Jul 8.
The World Symposium on Pulmonary Hypertension (WSPH) was organized by the World Health Organization in 1973 in response to an increase in pulmonary arterial hypertension in Europe caused by aminorex, an appetite suppressant. The mandate of this meeting was to review the latest clinical and scientific research and to formulate recommendations to improve the diagnosis and management of pulmonary hypertension (PH). Since 1998, the WSPH has met every five years and in 2018, the sixth annual WSPH revised the hemodynamic definition of PH. This two-part series will review the updated definition, classification, pathophysiology, presentation, diagnosis, management, and perioperative management of patients with PH. In the first part of this series, the definition, classification, pathophysiology, and presentation will be reviewed.
世界肺动脉高压研讨会（WSPH）由世界卫生组织于 1973 年组织召开，以应对因减肥药苯丙醇胺（aminorex）在欧洲引发的肺动脉高压发病率上升的情况。此次会议的任务是审查最新的临床和科学研究，并制定建议，以改善肺动脉高压（PH）的诊断和管理。自 1998 年以来，WSPH 每五年举行一次会议，2018 年第六届 WSPH 修订了 PH 的血流动力学定义。本系列文章共两部分，将回顾 PH 患者的更新定义、分类、病理生理学、临床表现、诊断、治疗以及围手术期管理。本系列文章的第一部分将回顾定义、分类、病理生理学和临床表现。
